01 1Hetero Labs Limited
02 1Jiangsu Hengrui Pharmaceuticals Co. , Ltd.
03 1Natco Pharma Limited.
04 1ScinoPharm Taiwan, Ltd.
05 1Shilpa Pharma Lifesciences Limited
06 1Synthimed Labs Private Limited
07 1Viyash Life Sciences Private Limited
62
PharmaCompass offers a list of Letrozole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Letrozole manufacturer or Letrozole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Letrozole manufacturer or Letrozole supplier.
PharmaCompass also assists you with knowing the Letrozole API Price utilized in the formulation of products. Letrozole API Price is not always fixed or binding as the Letrozole Price is obtained through a variety of data sources. The Letrozole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A H020 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of H020, including repackagers and relabelers. The FDA regulates H020 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. H020 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of H020 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A H020 supplier is an individual or a company that provides H020 active pharmaceutical ingredient (API) or H020 finished formulations upon request. The H020 suppliers may include H020 API manufacturers, exporters, distributors and traders.
click here to find a list of H020 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The H020 Drug Master File in Japan (H020 JDMF) empowers H020 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the H020 JDMF during the approval evaluation for pharmaceutical products. At the time of H020 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of H020 suppliers with JDMF on PharmaCompass.
We have 7 companies offering H020
Get in contact with the supplier of your choice:
